Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Total Costs & Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-14.1%
5Y CAGR+8.0%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
-14.1%/yr
vs +26.6%/yr prior
5Y CAGR
+8.0%/yr
Recent deceleration
Acceleration
-40.7pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$41.78M-48.9%
2024$81.81M-21.1%
2023$103.65M+57.1%
2022$66.00M+20.6%
2021$54.70M+92.8%
2020$28.38M-23.0%
2019$36.87M+43.5%
2018$25.70M+25.9%
2017$20.41M-14.3%
2016$23.82M-